title: Systemic lupus erythematosus: a consideration for antimicrobial prophylaxis.
abstract: Endothelial damage to heart valves, similar to that seen with rheumatic heart disease, occurs in 50% of all patients with systemic lupus erythematosus. Bacterial endocarditis is a consequence in 1% to 4% of these patients. This rate is greater than the incidence of endocarditis after rheumatic heart disease and compares favorably with the incidence of endocarditis in patients with prosthetic heart valves. At present, it is not possible to accurately delineate the subpopulation of patients with SLE that is at risk for this disease; hence, it is recommended that antibiotic prophylaxis (standard regimen suggested by the American Heart Association) be considered for all patients with systemic lupus erythematosus undergoing dental procedures associated with transient bacteremias.
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003730:Dental Care for Persons with Disabilities; D004697:Endocarditis, Bacterial / Q000517:prevention & control*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D011292:Premedication; D012306:Risk
chemical_list: D000900:Anti-Bacterial Agents